Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) exposed or refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies Meeting Abstract
| Authors: | Rodriguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Thuresson, M.; Harmenberg, J.; Harlin, O.; Richardson, P. G. |
| Abstract Title: | Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) exposed or refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | myeloma; multiple; mm; melflufen; melphalan flufenamide; peptide-drug conjugate; alkylator |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S426 |
| End Page: | S427 |
| Language: | English |
| ACCESSION: | WOS:000691910500390 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(21)01952-2 |
| Notes: | Meeting Abstract: MM-171 -- Source: Wos |
